Cargando…

Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users

OBJECTIVE: There is growing evidence regarding the numerous adverse effects of synthetic cannabinoids (SCBs) on the cardiovascular system; however, no studies have shown the cardiovascular effects of opioids using strain echocardiography. This study examines the cardiac structure and function using...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirkıran, Aykut, Albayrak, Neslihan, Albayrak, Yakup, Zorkun, Cafer Sadık
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998859/
https://www.ncbi.nlm.nih.gov/pubmed/29848923
http://dx.doi.org/10.14744/AnatolJCardiol.2018.76429
_version_ 1783331315651706880
author Demirkıran, Aykut
Albayrak, Neslihan
Albayrak, Yakup
Zorkun, Cafer Sadık
author_facet Demirkıran, Aykut
Albayrak, Neslihan
Albayrak, Yakup
Zorkun, Cafer Sadık
author_sort Demirkıran, Aykut
collection PubMed
description OBJECTIVE: There is growing evidence regarding the numerous adverse effects of synthetic cannabinoids (SCBs) on the cardiovascular system; however, no studies have shown the cardiovascular effects of opioids using strain echocardiography. This study examines the cardiac structure and function using echocardiographic strain imaging in heroin and synthetic cannabinoid users. METHODS: This double-blind study included patients who were admitted or referred to a rehabilitation center for heroin (n=31) and synthetic cannabinoid users (n=30). Heroin users and synthetic cannabinoid users were compared with healthy volunteers (n=32) using two-dimensional (2D) speckle-tracking (ST) echocardiography. RESULTS: No differences were found in the baseline characteristics and 2D echocardiography values. The mean global longitudinal strain value was −20.5%±2.4% for SCB users, −22.3%±2.4% for opioid users, and −22.5%±2.2% for healthy volunteers (p=0.024). The mean apical 2-chamber (AP2C) L-strain values were −20.1%±3.1%, −22.4%±3.0%, and −22.3%±2.8% for SCB users, opioid users, and healthy volunteers, respectively (p=0.032). The mean apical 4-chamber (AP4C) L-strain values were −20.7%±2.5% for SCB users, −23.2%±3.2% for opioid users, and −23.8%±3.1% for healthy volunteers (p<0.001). CONCLUSION: SCBs are potential causes of subclinical left ventricular dysfunction.
format Online
Article
Text
id pubmed-5998859
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-59988592018-06-18 Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users Demirkıran, Aykut Albayrak, Neslihan Albayrak, Yakup Zorkun, Cafer Sadık Anatol J Cardiol Original Investigation OBJECTIVE: There is growing evidence regarding the numerous adverse effects of synthetic cannabinoids (SCBs) on the cardiovascular system; however, no studies have shown the cardiovascular effects of opioids using strain echocardiography. This study examines the cardiac structure and function using echocardiographic strain imaging in heroin and synthetic cannabinoid users. METHODS: This double-blind study included patients who were admitted or referred to a rehabilitation center for heroin (n=31) and synthetic cannabinoid users (n=30). Heroin users and synthetic cannabinoid users were compared with healthy volunteers (n=32) using two-dimensional (2D) speckle-tracking (ST) echocardiography. RESULTS: No differences were found in the baseline characteristics and 2D echocardiography values. The mean global longitudinal strain value was −20.5%±2.4% for SCB users, −22.3%±2.4% for opioid users, and −22.5%±2.2% for healthy volunteers (p=0.024). The mean apical 2-chamber (AP2C) L-strain values were −20.1%±3.1%, −22.4%±3.0%, and −22.3%±2.8% for SCB users, opioid users, and healthy volunteers, respectively (p=0.032). The mean apical 4-chamber (AP4C) L-strain values were −20.7%±2.5% for SCB users, −23.2%±3.2% for opioid users, and −23.8%±3.1% for healthy volunteers (p<0.001). CONCLUSION: SCBs are potential causes of subclinical left ventricular dysfunction. Kare Publishing 2018-06 2018-05-24 /pmc/articles/PMC5998859/ /pubmed/29848923 http://dx.doi.org/10.14744/AnatolJCardiol.2018.76429 Text en Copyright: © 2018 Turkish Society of Cardiology http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Original Investigation
Demirkıran, Aykut
Albayrak, Neslihan
Albayrak, Yakup
Zorkun, Cafer Sadık
Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users
title Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users
title_full Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users
title_fullStr Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users
title_full_unstemmed Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users
title_short Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users
title_sort speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998859/
https://www.ncbi.nlm.nih.gov/pubmed/29848923
http://dx.doi.org/10.14744/AnatolJCardiol.2018.76429
work_keys_str_mv AT demirkıranaykut speckletrackingstrainassessmentofleftventriculardysfunctioninsyntheticcannabinoidandheroinusers
AT albayrakneslihan speckletrackingstrainassessmentofleftventriculardysfunctioninsyntheticcannabinoidandheroinusers
AT albayrakyakup speckletrackingstrainassessmentofleftventriculardysfunctioninsyntheticcannabinoidandheroinusers
AT zorkuncafersadık speckletrackingstrainassessmentofleftventriculardysfunctioninsyntheticcannabinoidandheroinusers